Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Annals of Clinical and Translational Neurology|November 29, 2021
Impact of T cells on neurodegeneration in anti-GAD65 limbic encephalitisAndre Dik, Guido Widman, Andreas Schulte-Mecklenbeck, et al.Frontiers in Immunology|January 9, 2023
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Alice Willison, Melanie Korsen, et al.Cells|April 11, 2025
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple SclerosisAlice G Willison, Ramona Hagler, Margit Weise, et al.Journal of Autoimmunity|January 9, 2023
Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitisSaskia Räuber, Christina B Schroeter, Christine Strippel, et al.Brain : a Journal of Neurology|April 13, 2021
Classification of neurological diseases using multi-dimensional CSF analysisCatharina C Gross, Andreas Schulte-Mecklenbeck, Lohith Madireddy, et al.Journal of Neurology|July 11, 2024
Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohortPaula Quint, Christina B Schroeter, Felix Kohle, et al.Elife|May 22, 2024
Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemiaTobias Weinberger, Messerer Denise, Markus Joppich, et al.Journal of Neuroinflammation|November 9, 2022
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitisChristina B Schroeter, Leoni Rolfes, K S Sophie Gothan, et al.Acta Neuropathologica|June 18, 2024
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravisChristina B Schroeter, Christopher Nelke, Frauke Stascheit, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 23, 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Melanie Korsen, Niklas Huntemann, et al.Pageof 5